Hypertension Trial, Recruiting NCT07341763 Sponsor: University of Waterloo Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT07341763
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a healthy adult (18 or older) who has narrowed/tunnel vision in both eyes caused by retinitis pigmentosa, rod-cone dystrophy, or advanced glaucoma.
  • Your vision, even with glasses or contact lenses, is no worse than 20/40, and your field of vision is no wider than 50 degrees in each eye (or 50 degrees when both eyes are tested together).
  • You may or may not use a long white cane to travel independently — both cane users and non-cane users may be eligible; if you do use a cane, you should be willing to bring your own.
  • You are able to make your own legal decisions and give your informed consent.
  • You have fully read and understood the consent information provided.
  • You are willing and able to follow instructions and attend all required appointments.

Who may not be able to join:

  • You are currently taking part in another eye-related study (you may need to wait at least one week, or four weeks if that study involved brain stimulation, before joining this trial).
  • You have been diagnosed with, or believe you may have, dementia.
  • You have been diagnosed with, or believe you may have, a cognitive (thinking or memory) impairment.
  • You have been diagnosed with, or believe you may have, a physical or movement condition that affects your ability to walk or keep your balance.
  • You have been diagnosed with, or believe you may have, a balance or inner-ear (vestibular) disorder that affects your movement or balance.
  • You are unable to follow the researchers' instructions.
  • You are expecting to have any eye treatment or eye surgery during the period of the study.
  • You have any additional eye condition (beyond retinitis pigmentosa, rod-cone dystrophy, or advanced glaucoma) that could reduce your vision — though wearing glasses or contact lenses, or having a mild cataract (grade 2 or below), is acceptable.
  • You have severe hearing loss.
  • You are pregnant or trying to become pregnant.
  • You have epilepsy or have ever had an epileptic seizure.
  • You have an implanted medication pump or an implanted electronic device such as a pacemaker or defibrillator.
  • You have any metal implants in your head (tooth fillings are acceptable).
  • You have any active electrical implants anywhere in your body, particularly in the head area.
  • You take medication for a psychiatric or neurological condition such as depression or schizophrenia (confirm with trial site).
  • You have sensitive or irritated skin on your face or head, a skin condition on your face, or regularly use medication to treat facial skin irritation.
  • You experience recurring or frequent headaches.
  • You have had a previous head injury, skull fracture, or brain or head surgery.
  • You have heart disease, a neurological condition, or a history of heart or brain surgery.
  • You have or have had a brain tumour (cancerous or non-cancerous) or any other abnormality in your brain structure.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Benjamin Thompson, PhD, University of Waterloo School of Optometry and Vision Science

Phone: 1+5198884567

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Waterloo
Registry
ClinicalTrials.gov
Start date
1 July 2026
Est. completion
31 August 2027

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Percentage preferred walking speed (PPWS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov